Echo Therapeutics, Inc. (NASDAQ: ECTE) is changing the blood glucose monitoring industry. The company has successfully demonstrated the ability to continuously monitor blood glucose non-invasively in healthy, Type I, Type II and hospital patients. Echo’s precise exfoliator is a revolution in personal monitoring technology. It is a proprietary skin preparation device that painlessly exfoliates a precise portion of the outer layer of dead skin for optimal glucose and analyte extraction. For more information, visit the company’s website at www.echotx.com.